1 JAKAFI (RUXOLITINIB PHOSPHATE) | 10 of 580 | 3220 prescriptions Less than 1% of all prescriptions | 2990 | 460 patients 39% of all patients | < 11 | |
2 BOSULIF (BOSUTINIB) | 10 of 110 | 1240 prescriptions Less than 1% of all prescriptions | 1240 | 190 patients 16% of all patients | 190 patients 16% of all patients | |
3 HYDROXYUREA | 90 of 1570 | 910 prescriptions Less than 1% of all prescriptions | | 240 patients 20% of all patients | < 11 | |
4 ALLOPURINOL | 170 of 510 | 260 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
5 DANAZOL | 10 of 20 | 310 prescriptions Less than 1% of all prescriptions | | 110 patients 9% of all patients | < 11 | |
6 SPRYCEL (DASATINIB) | 80 of 250 | 280 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
7 TASIGNA (NILOTINIB HCL) | 10 of 360 | 250 prescriptions Less than 1% of all prescriptions | 250 | < 11 | < 11 | |
8 IMATINIB MESYLATE | 290 of 850 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 ANAGRELIDE HCL | 70 of 260 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
10 ICLUSIG (PONATINIB HCL) | 10 of 20 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
11 IMBRUVICA (IBRUTINIB) | 460 of 1180 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
12 ULORIC (FEBUXOSTAT) | 20 of 20 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |